|
1
|
A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples.
|
Med Microbiol Immunol
|
2007
|
2.64
|
|
2
|
Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007.
|
J Antimicrob Chemother
|
2011
|
2.26
|
|
3
|
Improved detection of blood stream pathogens by real-time PCR in severe sepsis.
|
Intensive Care Med
|
2009
|
1.51
|
|
4
|
Zoonotic babesiosis: overview of the disease and novel aspects of pathogen identity.
|
Ticks Tick Borne Dis
|
2009
|
1.42
|
|
5
|
Potential clinical utility of polymerase chain reaction in microbiological testing for sepsis.
|
Crit Care Med
|
2009
|
1.29
|
|
6
|
First case of human babesiosis in Germany - Clinical presentation and molecular characterisation of the pathogen.
|
Int J Med Microbiol
|
2007
|
1.28
|
|
7
|
Is serological testing a reliable tool in laboratory diagnosis of syphilis? Meta-analysis of eight external quality control surveys performed by the german infection serology proficiency testing program.
|
J Clin Microbiol
|
2006
|
1.17
|
|
8
|
Individual cases of autochthonous malaria in Evros Province, northern Greece: serological aspects.
|
Parasitol Res
|
2002
|
1.06
|
|
9
|
Surface-associated motility, a common trait of clinical isolates of Acinetobacter baumannii, depends on 1,3-diaminopropane.
|
Int J Med Microbiol
|
2012
|
0.98
|
|
10
|
Serologic evidence for effective production of cytolysin A in Salmonella enterica serovars typhi and paratyphi A during human infection.
|
Infect Immun
|
2006
|
0.92
|
|
11
|
The borrelial fibronectin-binding protein RevA is an early antigen of human Lyme disease.
|
Clin Vaccine Immunol
|
2009
|
0.91
|
|
12
|
Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1.
|
PLoS Pathog
|
2010
|
0.90
|
|
13
|
Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease.
|
Clin Vaccine Immunol
|
2007
|
0.88
|
|
14
|
Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease.
|
J Clin Microbiol
|
2008
|
0.88
|
|
15
|
[Flap Amputation in Mycobacterium chelonae Keratitis after Laser-in-situ Keratomileusis (LASIK)].
|
Klin Monbl Augenheilkd
|
2003
|
0.86
|
|
16
|
Comparison of in vitro activities of tigecycline, doxycycline, and tetracycline against the spirochete Borrelia burgdorferi.
|
Ticks Tick Borne Dis
|
2010
|
0.85
|
|
17
|
Systematic analysis highlights the key role of TLR2/NF-kappaB/MAP kinase signaling for IL-8 induction by macrophage-like THP-1 cells under influence of Borrelia burgdorferi lysates.
|
Int J Biochem Cell Biol
|
2008
|
0.83
|
|
18
|
Primary intestinal aspergillosis after high-dose chemotherapy and autologous stem cell rescue.
|
Pediatr Infect Dis J
|
2006
|
0.82
|
|
19
|
Generation and characterization of anti-Candida T cells as potential immunotherapy in patients with Candida infection after allogeneic hematopoietic stem-cell transplant.
|
J Infect Dis
|
2007
|
0.78
|
|
20
|
In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease.
|
Antimicrob Agents Chemother
|
2008
|
0.75
|
|
21
|
[Babesiosis in an immunocompromised German patient].
|
Med Klin (Munich)
|
2008
|
0.75
|
|
22
|
Real-time PCR-based identification of bacterial and fungal pathogens from blood samples.
|
Methods Mol Biol
|
2015
|
0.75
|
|
23
|
In vitro activities of faropenem, ertapenem, imipenem and meropenem against Borrelia burgdorferi s.l.
|
Int J Antimicrob Agents
|
2007
|
0.75
|